Company Details
| Sector | PHARMACEUTICALS |
| Address | 35 - Dockyard Road West Wharf Karachi |
| Auditor | Yousuf Adil, Chartered Accountants |
| Registrar | CDC Share Registrar Services Limited CDC House, 99 - B, Block - B S.M.C.H.S., Main Shahra-e-Faisal Karachi |
| Website | www.pk.gsk.com |
| Fiscal Year | December |
| Details |
Details
GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V.@ incorporated in Netherlands@ whereas its ultimate parent company is GlaxoSmithKline plc@ UK (GSK plc).
Company Announcements
| Date/Time | Announcement |
|---|---|
| 08/03/2017 16:03:05 | FINANCIAL RESULT FOR THE YEAR ENDED 31/12/2016 DIVIDEND = 60% PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 4,352.881 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 2,7622.185 EPS = 8.68 ANNUAL GENERAL MEETING WILL BE HELD ON 24/04/2017 BOOK CLOSURE FROM 18/04/2017 BOOK CLOSURE TO 24/04/2017 |
| 26/10/2016 14:18:24 | PROFIT/LOSS AFTER TAXATION RS. IN MILLION 1,790.035 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 2,827.406 FINANCIAL RESULT FOR THE NINE MONTHS ENDED 30/09/2016 EPS = 5.62 |
| 26/08/2016 16:18:45 | PROFIT/LOSS AFTER TAXATION RS. IN MILLION 1,073.339 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 1,609.572 FINANCIAL RESULT FOR THE HALF YEAR ENDED 30/06/2016 EPS = 3.37 |
| 27/04/2016 11:42:26 | FINANCIAL RESULT FOR THE FIRST QUARTER ENDED 31/03/2016 EPS = 2.19 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 697.188 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 914.134 |
| 30/03/2016 15:13:29 | EPS = 8.30 BOOK CLOSURE TO 27/04/2016 BOOK CLOSURE FROM 20/04/2016 ANNUAL GENERAL MEETING WILL BE HELD ON 27/04/2016 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 2,643.230 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 3,514.106 DIVIDEND = 40% FINANCIAL RESULT FOR THE YEAR ENDED 31/12/2015 |